116 related articles for article (PubMed ID: 11314598)
1. Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation.
Mori T; Takase H; Toide K; Hirano T; Kambe T; Nakayama N; Schwartz A
Cardiovasc Drug Rev; 2001; 19(1):1-8. PubMed ID: 11314598
[TBL] [Abstract][Full Text] [Related]
2. Pranidipine, a new 1,4-dihydropyridine calcium channel blocker, enhances cyclic GMP-independent nitric oxide-induced relaxation of the rat aorta.
Mori T; Takeuchi T; Ohura M; Miyakoda G; Fujiki H; Orito K; Yoshida K; Hirano T; Yamamura Y; Sumida T; Nakaya Y; Satake H; Hata F
Mol Cell Biochem; 1998 Jan; 178(1-2):335-43. PubMed ID: 9546618
[TBL] [Abstract][Full Text] [Related]
3. Pranidipine enhances the action of nitric oxide released from endothelial cells.
Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
[TBL] [Abstract][Full Text] [Related]
4. Pranidipine enhances relaxation produced by endothelium-derived relaxing factor in carotid artery.
Koshita M; Takano H; Nakahira Y; Suzuki H
Eur J Pharmacol; 1999 Dec; 385(2-3):191-7. PubMed ID: 10607875
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant effects of Cerebralcare Granule® are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta.
Qu Z; Zhang J; Gao W; Chen H; Guo H; Wang T; Li H; Liu C
J Ethnopharmacol; 2014 Aug; 155(1):572-9. PubMed ID: 24924524
[TBL] [Abstract][Full Text] [Related]
7. Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: comparison with nifedipine and amlodipine.
Hirano T; Ohura M; Orito K; Fujiki H; Miyakoda G; Mori T
Eur J Pharmacol; 1997 Apr; 324(2-3):201-4. PubMed ID: 9145772
[TBL] [Abstract][Full Text] [Related]
8. Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator.
Hirano T; Mori T; Kido M; Toide K; Ohura M; Fujiki H; Orito K; Yoshida K; Ikezono K; Sumida T; Nakayama N; Yabuuchi Y
Fundam Clin Pharmacol; 1999; 13(6):650-5. PubMed ID: 10626752
[TBL] [Abstract][Full Text] [Related]
9. Relative significance of the nitric oxide (NO)/cGMP pathway and K+ channel activation in endothelium-dependent vasodilation in the femoral artery of developing piglets.
Støen R; Lossius K; Persson AA; Karlsson JO
Acta Physiol Scand; 2001 Jan; 171(1):29-35. PubMed ID: 11350260
[TBL] [Abstract][Full Text] [Related]
10. Involvement of H2O2 in superoxide-dismutase-induced enhancement of endothelium-dependent relaxation in rabbit mesenteric resistance artery.
Itoh T; Kajikuri J; Hattori T; Kusama N; Yamamoto T
Br J Pharmacol; 2003 May; 139(2):444-56. PubMed ID: 12770950
[TBL] [Abstract][Full Text] [Related]
11. The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries.
Vilaine JP; Biondi ML; Villeneuve N; Feletou M; Peglion JL; Vanhoutte PM
Eur J Pharmacol; 1991 May; 197(1):41-8. PubMed ID: 1654260
[TBL] [Abstract][Full Text] [Related]
12. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (EDRF) enhances the vasorelaxing effect of dihydropyridine calcium antagonists in isolated human middle cerebral arteries.
Akopov SE
Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):101-4. PubMed ID: 8740241
[TBL] [Abstract][Full Text] [Related]
14. Moderate hypothermia and responses to calcium channel blockers - Role of the nitric oxide.
Canbolat S; Nurullahoglu Atalik KE
Physiol Int; 2018 Mar; 105(1):53-60. PubMed ID: 29602295
[TBL] [Abstract][Full Text] [Related]
15. Dual actions of cilnidipine in human internal thoracic artery: inhibition of calcium channels and enhancement of endothelial nitric oxide synthase.
Fan L; Yang Q; Xiao XQ; Grove KL; Huang Y; Chen ZW; Furnary A; He GW
J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1063-9. PubMed ID: 20599230
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the potent and long-lasting antihypertensive action of the new calcium channel blocker pranidipine. Evidence for strong affinity to the calcium channels or membranes.
Miyakoda G; Nakayama N; Matsui K; Yabuuchi Y
Arzneimittelforschung; 1995 Apr; 45(4):471-5. PubMed ID: 7779144
[TBL] [Abstract][Full Text] [Related]
17. A novel capsaicin derivative VOA induced relaxation in rat mesenteric and aortic arteries: involvement of CGRP, NO, cGMP, and endothelium-dependent activities.
Lo YC; Hsiao HC; Wu DC; Lin RJ; Liang JC; Yeh JL; Chen IJ
J Cardiovasc Pharmacol; 2003 Oct; 42(4):511-20. PubMed ID: 14508237
[TBL] [Abstract][Full Text] [Related]
18. Attenuated endothelium-mediated relaxation by acteoside in rat aorta: Role of endothelial [Ca2+]i and nitric oxide/cyclic GMP pathway.
Lau CW; Chen ZY; Wong CM; Yao X; He Z; Xu H; Huang Y
Life Sci; 2004 Jul; 75(10):1149-57. PubMed ID: 15219803
[TBL] [Abstract][Full Text] [Related]
19. Endothelium dependence and gestational regulation of inhibition of vascular tone by magnesium sulfate in rat aorta.
Longo M; Jain V; Vedernikov YP; Facchinetti F; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Apr; 184(5):971-8. PubMed ID: 11303207
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxant effects of Shunaoxin pill are mediated by NO/cGMP pathway, HO/CO pathway and calcium channel blockade in isolated rat thoracic aorta.
Huo L; Zhang J; Qu Z; Chen H; Li Y; Gao W
J Ethnopharmacol; 2015 Sep; 173():352-60. PubMed ID: 26239154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
